PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23973922-1	2013	BACKGROUND & AIMS: Decreased levels or function of nucleotide-binding oligomerization domain 2 (NOD2) are associated with Crohn"s disease.	Adenosine Monophosphate	12-15	nucleotide-binding oligomerization domain containing 2	Mus musculus	55-98	
23512834-5	2014	Specifically, we hypothesised that Nod2(-/-) B6 mice would display reduced AMP expression and activity.	Adenosine Monophosphate	75-78	nucleotide-binding oligomerization domain containing 2	Mus musculus	35-39	
23512834-6	2014	DESIGN: Wild-type (WT) and Nod2(-/-) B6 ileal AMP expression was assessed via real-time PCR, acid urea polyacrylamide gel electrophoresis and mass spectrometry.	Adenosine Monophosphate	46-49	nucleotide-binding oligomerization domain containing 2	Mus musculus	27-31	
23973922-1	2013	BACKGROUND & AIMS: Decreased levels or function of nucleotide-binding oligomerization domain 2 (NOD2) are associated with Crohn"s disease.	Adenosine Monophosphate	12-15	nucleotide-binding oligomerization domain containing 2	Mus musculus	100-104	
17915219-1	2007	BACKGROUND & AIMS: Mutations in the CARD15 gene encoding NOD2 are susceptibility factors in Crohn"s disease.	Adenosine Monophosphate	12-15	nucleotide-binding oligomerization domain containing 2	Mus musculus	40-46	
17915219-1	2007	BACKGROUND & AIMS: Mutations in the CARD15 gene encoding NOD2 are susceptibility factors in Crohn"s disease.	Adenosine Monophosphate	12-15	nucleotide-binding oligomerization domain containing 2	Mus musculus	61-65